X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KOPRAN LTD. Share Price   (KPRL)

Here is the latest stock price and chart of KOPRAN LTD.. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jun 22, 2017 (Close)
Price (Rs)84.40 Open (Rs) 85.25 High (Rs) 86.50 Low (Rs) 84.00
% Change-0.12 Volume 82,681 Value (Rs) 7,031,667 52-Week H/L 102.50 / 42.70
Live NSE Quotes Jun 22, 2017 (Close)
Price (Rs)84.45 Open (Rs) 85.10 High (Rs) 86.45 Low (Rs) 83.90
% Change-0.35 Volume 339,783 Value (Rs) 28,871,319 52-Week H/L 102.45 / 42.60
  BSE Sensex | CNX Nifty

Charts
KOPRAN LTD. Share Price Chart (Rs) - 1 Year
Loading...
 
     
PERIOD
Advanced Charts new


Today's Market

Sensex Sheds Morning Gains to Finish Flat; Energy Stocks Continue to Fall(Closing)

Indian share markets erased gains it made earlier in the day on heavy selling in oil & gas stocks, realty stocks, metal stocks and PSU stocks amid weak European cues.

Related Views On News

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Digital Transactions were Growing Faster Before Demonetisation(Vivek Kaul's Diary)

Jun 12, 2017

Which brings us back to the basic question, why was demonetisation carried out?

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

How to Trade Political Risk(Daily Profit Hunter)

Jun 9, 2017

You can profit from political risk by learning to trade derivatives markets with our tailored online learning course.

Should You Trade In Mutual Funds As You Do In Stocks?(Outside View)

Jun 10, 2017

Trading is not synonymous with mutual funds, PersonalFN explains.

Which Way Will Inflation Go?(Chart Of The Day)

Jun 10, 2017

RBI and government at loggerheads over interest rates.

More

TRACK KOPRAN LTD.

  • Track your investment in KOPRAN LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS